33,902 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Burney Co.

Burney Co. bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 33,902 shares of the company's stock, valued at approximately $1,810,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. GAMMA Investing LLC raised its position in shares of Doximity by 20.6% during the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock valued at $93,000 after buying an additional 296 shares in the last quarter. MetLife Investment Management LLC increased its stake in Doximity by 0.6% in the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company's stock valued at $2,835,000 after acquiring an additional 363 shares during the last quarter. First Horizon Advisors Inc. raised its position in Doximity by 22.5% during the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock valued at $91,000 after purchasing an additional 384 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock worth $34,000 after purchasing an additional 603 shares during the last quarter. Finally, KBC Group NV boosted its holdings in shares of Doximity by 22.9% in the 3rd quarter. KBC Group NV now owns 3,296 shares of the company's stock worth $144,000 after purchasing an additional 614 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Doximity Stock Up 0.4 %

Shares of DOCS traded up $0.23 during mid-day trading on Thursday, hitting $53.20. 672,704 shares of the company's stock traded hands, compared to its average volume of 1,480,900. The firm has a market capitalization of $9.93 billion, a P/E ratio of 61.15, a PEG ratio of 4.12 and a beta of 1.38. The business's 50-day moving average price is $53.61 and its 200-day moving average price is $42.17. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $61.75.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the company. JPMorgan Chase & Co. raised their price objective on Doximity from $30.00 to $48.00 and gave the company a "neutral" rating in a report on Thursday, November 21st. Mizuho initiated coverage on shares of Doximity in a research note on Wednesday, December 4th. They set a "neutral" rating and a $55.00 price target on the stock. Morgan Stanley upgraded shares of Doximity from an "underweight" rating to an "equal weight" rating and boosted their price objective for the stock from $33.00 to $53.00 in a report on Thursday, November 14th. Raymond James reaffirmed an "outperform" rating and set a $65.00 target price (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. Finally, The Goldman Sachs Group started coverage on shares of Doximity in a research report on Friday, November 15th. They issued a "neutral" rating and a $58.00 target price on the stock. Thirteen analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Doximity presently has an average rating of "Hold" and a consensus target price of $53.12.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.